{"id":10516,"date":"2015-12-10T12:07:57","date_gmt":"2015-12-10T12:07:57","guid":{"rendered":"http:\/\/drupal.test\/projects\/indicateurs-genetiques-viraux-et-humains-de-la-reaction-aux-therapies-du-vih\/"},"modified":"2022-07-26T15:35:47","modified_gmt":"2022-07-26T19:35:47","slug":"indicateurs-genetiques-viraux-et-humains-de-la-reaction-aux-therapies-du-vih","status":"publish","type":"project","link":"https:\/\/genomecanada.ca\/fr\/project\/indicateurs-genetiques-viraux-et-humains-de-la-reaction-aux-therapies-du-vih\/","title":{"rendered":"Indicateurs g\u00e9n\u00e9tiques viraux et humains de la r\u00e9action aux th\u00e9rapies  du VIH"},"content":{"rendered":"<p>Le \u00ab cocktail \u00bb de m\u00e9dicaments anti\u00ad-VIH a transform\u00e9 le sida auparavant mortel en une maladie qu\u2019il est possible de g\u00e9rer. Malheureusement, le VIH peut devenir r\u00e9sistant \u00e0 ces m\u00e9dicaments, ce qui fait \u00e9voluer la maladie en sida et accro\u00eet les risques de transmission du virus. L&rsquo;\u00e9quipe de recherche, dirig\u00e9e par M. Richard Harrigan et le Dr Julio Montaner, \u00e9laborera un test sur la r\u00e9sistance aux m\u00e9dicaments, bas\u00e9 sur l&rsquo;ADN individuel et l\u2019ADN du virus. Les co\u00fbts des m\u00e9dicaments anti\u00adVIH tout au long de la vie atteignent de 250 000 $ \u00e0 500 000 $, mais il existe de nombreux \u00e9l\u00e9ments multiplicateurs de l\u2019impact \u00e9conomique d\u2019une infection \u00e0 VIH. Les nations pour lesquelles les taux d\u2019infection \u00e0 VIH sont \u00e9lev\u00e9s observent l\u2019importance de ces r\u00e9percussions sur le PIB au point qu\u2019elles ne peuvent plus les assumer. L\u2019\u00e9quipe de projet met \u00e9galement au point des syst\u00e8mes de surveillance en temps r\u00e9el de la r\u00e9sistance aux m\u00e9dicaments pour obtenir des alertes rapides des \u00ab points chauds \u00bb g\u00e9ographiques ou d\u00e9mographiques o\u00f9 les taux de r\u00e9sistance sont les plus \u00e9lev\u00e9s et les risques de transmission les plus \u00e9lev\u00e9s. La mod\u00e9lisation math\u00e9matique donne \u00e0 penser que la mise en \u0153uvre de ce projet pilote dans le quartier Downtown East Side de Vancouver et \u00e0 Prince George pourrait faire \u00e9viter jusqu\u2019\u00e0 173 infections \u00e0 VIH au cours des cinq premi\u00e8res ann\u00e9es, ce qui repr\u00e9sente environ 65 millions de dollars en co\u00fbts \u00e9vit\u00e9s des traitements anti\u00ad-VIH \u00e0 vie.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le \u00ab cocktail \u00bb de m\u00e9dicaments anti\u00ad-VIH a transform\u00e9 le sida auparavant mortel en une maladie qu\u2019il est possible de g\u00e9rer. Malheureusement, le VIH peut devenir r\u00e9sistant \u00e0 ces m\u00e9dicaments, ce qui fait \u00e9voluer la maladie en sida et accro\u00eet les risques de transmission du virus. L&rsquo;\u00e9quipe de recherche, dirig\u00e9e par M. Richard Harrigan et [&hellip;]<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"project-categories":[93],"genome-competitions":[227],"project-sector":[],"genome_centres":[105],"class_list":["post-10516","project","type-project","status-publish","hentry","project-categories-large-scale-science-fr","genome-competitions-concours-2012-projets-de-recherche-appliquee-a-grande-echelle-genomique-et-sante-personnalisee","genome_centres-genome-british-columbia-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Indicateurs g\u00e9n\u00e9tiques viraux et humains de la r\u00e9action aux th\u00e9rapies du VIH - GenomeCanada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genomecanada.ca\/fr\/project\/indicateurs-genetiques-viraux-et-humains-de-la-reaction-aux-therapies-du-vih\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Indicateurs g\u00e9n\u00e9tiques viraux et humains de la r\u00e9action aux th\u00e9rapies du VIH - GenomeCanada\" \/>\n<meta property=\"og:description\" content=\"Le \u00ab cocktail \u00bb de m\u00e9dicaments anti\u00ad-VIH a transform\u00e9 le sida auparavant mortel en une maladie qu\u2019il est possible de g\u00e9rer. Malheureusement, le VIH peut devenir r\u00e9sistant \u00e0 ces m\u00e9dicaments, ce qui fait \u00e9voluer la maladie en sida et accro\u00eet les risques de transmission du virus. L&rsquo;\u00e9quipe de recherche, dirig\u00e9e par M. Richard Harrigan et [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genomecanada.ca\/fr\/project\/indicateurs-genetiques-viraux-et-humains-de-la-reaction-aux-therapies-du-vih\/\" \/>\n<meta property=\"og:site_name\" content=\"GenomeCanada\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-26T19:35:47+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/indicateurs-genetiques-viraux-et-humains-de-la-reaction-aux-therapies-du-vih\\\/\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/indicateurs-genetiques-viraux-et-humains-de-la-reaction-aux-therapies-du-vih\\\/\",\"name\":\"Indicateurs g\u00e9n\u00e9tiques viraux et humains de la r\u00e9action aux th\u00e9rapies du VIH - GenomeCanada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#website\"},\"datePublished\":\"2015-12-10T12:07:57+00:00\",\"dateModified\":\"2022-07-26T19:35:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/indicateurs-genetiques-viraux-et-humains-de-la-reaction-aux-therapies-du-vih\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/indicateurs-genetiques-viraux-et-humains-de-la-reaction-aux-therapies-du-vih\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/indicateurs-genetiques-viraux-et-humains-de-la-reaction-aux-therapies-du-vih\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Indicateurs g\u00e9n\u00e9tiques viraux et humains de la r\u00e9action aux th\u00e9rapies du VIH\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\",\"name\":\"GenomeCanada\",\"description\":\"Harnessing the transformative power of genomics\",\"publisher\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#organization\",\"name\":\"GenomeCanada\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"contentUrl\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"width\":285,\"height\":180,\"caption\":\"GenomeCanada\"},\"image\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Indicateurs g\u00e9n\u00e9tiques viraux et humains de la r\u00e9action aux th\u00e9rapies du VIH - GenomeCanada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genomecanada.ca\/fr\/project\/indicateurs-genetiques-viraux-et-humains-de-la-reaction-aux-therapies-du-vih\/","og_locale":"fr_FR","og_type":"article","og_title":"Indicateurs g\u00e9n\u00e9tiques viraux et humains de la r\u00e9action aux th\u00e9rapies du VIH - GenomeCanada","og_description":"Le \u00ab cocktail \u00bb de m\u00e9dicaments anti\u00ad-VIH a transform\u00e9 le sida auparavant mortel en une maladie qu\u2019il est possible de g\u00e9rer. Malheureusement, le VIH peut devenir r\u00e9sistant \u00e0 ces m\u00e9dicaments, ce qui fait \u00e9voluer la maladie en sida et accro\u00eet les risques de transmission du virus. L&rsquo;\u00e9quipe de recherche, dirig\u00e9e par M. Richard Harrigan et [&hellip;]","og_url":"https:\/\/genomecanada.ca\/fr\/project\/indicateurs-genetiques-viraux-et-humains-de-la-reaction-aux-therapies-du-vih\/","og_site_name":"GenomeCanada","article_modified_time":"2022-07-26T19:35:47+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/genomecanada.ca\/fr\/project\/indicateurs-genetiques-viraux-et-humains-de-la-reaction-aux-therapies-du-vih\/","url":"https:\/\/genomecanada.ca\/fr\/project\/indicateurs-genetiques-viraux-et-humains-de-la-reaction-aux-therapies-du-vih\/","name":"Indicateurs g\u00e9n\u00e9tiques viraux et humains de la r\u00e9action aux th\u00e9rapies du VIH - GenomeCanada","isPartOf":{"@id":"https:\/\/genomecanada.ca\/fr\/#website"},"datePublished":"2015-12-10T12:07:57+00:00","dateModified":"2022-07-26T19:35:47+00:00","breadcrumb":{"@id":"https:\/\/genomecanada.ca\/fr\/project\/indicateurs-genetiques-viraux-et-humains-de-la-reaction-aux-therapies-du-vih\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genomecanada.ca\/fr\/project\/indicateurs-genetiques-viraux-et-humains-de-la-reaction-aux-therapies-du-vih\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/genomecanada.ca\/fr\/project\/indicateurs-genetiques-viraux-et-humains-de-la-reaction-aux-therapies-du-vih\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genomecanada.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Indicateurs g\u00e9n\u00e9tiques viraux et humains de la r\u00e9action aux th\u00e9rapies du VIH"}]},{"@type":"WebSite","@id":"https:\/\/genomecanada.ca\/fr\/#website","url":"https:\/\/genomecanada.ca\/fr\/","name":"GenomeCanada","description":"Harnessing the transformative power of genomics","publisher":{"@id":"https:\/\/genomecanada.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genomecanada.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/genomecanada.ca\/fr\/#organization","name":"GenomeCanada","url":"https:\/\/genomecanada.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/genomecanada.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","contentUrl":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","width":285,"height":180,"caption":"GenomeCanada"},"image":{"@id":"https:\/\/genomecanada.ca\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/10516","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/types\/project"}],"version-history":[{"count":0,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/10516\/revisions"}],"wp:attachment":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/media?parent=10516"}],"wp:term":[{"taxonomy":"project-categories","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-categories?post=10516"},{"taxonomy":"genome-competitions","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome-competitions?post=10516"},{"taxonomy":"project-sector","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-sector?post=10516"},{"taxonomy":"genome_centres","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome_centres?post=10516"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}